MCOM’s Dr. Xingmin Sun Recognized with Excellence in Innovation Awards

Xingmin Sun, PhD, Associate Professor in USF Health Morsani College of Medicine’s Department of Molecular Medicine, was one of five USF faculty members recognized for this year’s Excellence in Innovation Awards. The Excellence in Innovation Awards annually recognizes USF faculty who have demonstrated exceptional achievement in innovation and research. Dr. Sun’s research is focused Clostridium difficile, a toxin-producing bacteria that causes a severe form of diarrhea in people who have taken antibiotics that alter their normal colon bacteria. The infection has become a worldwide public health crisis. Dr. Sun has filed a series of patent applications on vaccines and is moving toward licensing his inventions for development as a potential treatment. Additionally, Dr. Sun is collaborating with USF chemists to develop antimicrobial agents to use against Clostridium difficile and continues to publish basic research that guides other scientists in the fight against it.


The Sun Lab focuses on the pathogenesis of Clostridium difficile infection (CDI) and development of novel preventive and therapeutic agents against CDI by using multidisciplinary approaches.


Dr. Sun has his PhD in Natural Sciences from the University of Kiel, Germany. He earned his Master Degree in Veterinary Microbiology and Immunology from the Nanjing Agricultural University. He is an Associate Professor with tenure in the Department of Molecular Medicine, College of Medicine at the University of South Florida (USF). He holds secondary appointment in the Department of Internal Medicine, Department of Cell Biology, Microbiology & Molecular Biology, and USF Genomics.  ​​Dr. Sun is a NIH Career Development Awardee. His research is supported by several NIH grants including R01, R21, R03 as well as internal seed grants and contracts.  He serves on Editorial Boards for “Infection and Immunity”, “Applied and Environmental Microbiology”. He also serves Review Editor for “Frontiers in Cellular and Infection Microbiology”, and acts as an ad-hoc reviewer for 10 other journals. In addition, Dr. Sun has been actively serving NIH study section panels.


Xingmin Sun, PhD was interviewed at the American Society for Microbiology (ASM) Microbe 2018 Conference, held June 7-11 in Atlanta, Ga.



USF is one of the nation’s most innovative public research universities, ranking seventh among American public research universities and 16th among all universities worldwide in generating new U.S. utility patents.

“USF continues to earn recognition as a hub of innovation and invention because of the quality of our faculty’s research,” said USF President Steve Currall. “Through their commitment to research and discovery, these five award-winners are creating solutions to challenges that affect communities locally and throughout the world.”

The Excellence in Innovation Awards also recognizes faculty for their efforts in taking inventions to market through the creation of new startups; commercialization to their new technologies; and advancing the research and development process through publishing their work in prestigious journals and securing competitive grants to support their projects. This year’s awards cover achievements in innovation from January 1, 2018, through June 30, 2019. Nominations were reviewed by members of the USF chapter of the National Academy of Inventors.

The winners will be celebrated at a luncheon on Jan. 27 at Discovery Hall in the USF Research Park.


(October 22, 2018) Xingmin Sun, PhD was one of fourteen USF faculty members recognized with the 2018 Outstanding Research Achievement Awards.